UBC's Blog

UBC is committed to sharing ideas & insights with the pharmaceutical & biotech industry to address the full product lifecycle & support the development & commercialization of safe & effective products.

 

UBC - September 10, 2012
Last month, the Centers for Disease Control and Prevention (CDC) published its final recommendation that all U.S. baby boomers should get a one-time test for the hepatitis C virus.  This recommendation has been a reminder to us...
, Vice President, Business Development - August 29, 2012
Small patient populations need big solutions.  And, as exhibited by the table below featured in a recent FierceBiotech article, Express Scripts continues to show manufacturers that there is strength in size. The table, created by...
Patrick Lindsay, President - August 17, 2012
Express Scripts has announced a plan to enhance and expand our pharmaceutical and biotechnology commercial platform offering by combining United BioSource Corporation (UBC) and HealthBridge Pharma & Biotech. The April 2, 2012,...
, Vice President, Business Development - August 16, 2012
Much like patient populations, successful launches come in all sizes.  Congratulations go to Regeneron this quarter on the success of the EYLEA® (aflibercept) Injection, which was approved by the FDA in November 2011 and is...
, Vice President, Business Development - August 07, 2012
More than half of the cancer drugs newly approved in 2011 are administered orally.  Oral oncology medications make therapy more manageable and convenient for patients.  However, these therapies can pose potential challenges...

Pages